Tempus AI, Inc. (NASDAQ:TEM) CEO Sells $5,029,972.05 in Stock

Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky sold 74,485 shares of Tempus AI stock in a transaction that occurred on Wednesday, February 5th. The shares were sold at an average price of $67.53, for a total value of $5,029,972.05. Following the sale, the chief executive officer now directly owns 5,458,502 shares in the company, valued at approximately $368,612,640.06. This trade represents a 1.35 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Tempus AI Price Performance

Shares of NASDAQ TEM opened at $68.96 on Monday. The stock’s fifty day simple moving average is $44.49 and its 200 day simple moving average is $49.16. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. Tempus AI, Inc. has a 52-week low of $22.89 and a 52-week high of $79.49.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the company. Guggenheim started coverage on Tempus AI in a research report on Monday, December 9th. They issued a “buy” rating and a $74.00 target price on the stock. Loop Capital cut their price objective on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a research note on Tuesday, January 14th. Wolfe Research began coverage on shares of Tempus AI in a research report on Friday, December 13th. They issued an “outperform” rating and a $60.00 target price for the company. Needham & Company LLC reiterated a “buy” rating and set a $56.00 price objective on shares of Tempus AI in a research note on Tuesday, January 14th. Finally, Piper Sandler reiterated a “neutral” rating and set a $70.00 price target (up from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Three equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $58.55.

Hedge Funds Weigh In On Tempus AI

Institutional investors have recently bought and sold shares of the stock. ARK Investment Management LLC boosted its holdings in shares of Tempus AI by 132.1% in the fourth quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company’s stock worth $186,343,000 after buying an additional 3,141,487 shares during the period. NEA Management Company LLC lifted its position in shares of Tempus AI by 17.8% in the 3rd quarter. NEA Management Company LLC now owns 5,385,979 shares of the company’s stock valued at $304,846,000 after acquiring an additional 813,169 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. boosted its stake in Tempus AI by 166.0% in the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company’s stock worth $109,352,000 after purchasing an additional 2,021,394 shares during the period. Franklin Resources Inc. grew its position in Tempus AI by 1.0% during the 3rd quarter. Franklin Resources Inc. now owns 811,311 shares of the company’s stock worth $45,920,000 after purchasing an additional 8,387 shares in the last quarter. Finally, Millennium Management LLC acquired a new stake in Tempus AI during the 2nd quarter valued at $8,067,000. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.